Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes.
Yu S, Fan Z, Ma L, Wang Y, Huang F, Zhang Q, Huang J, Wang S, Xu N, Xuan L, Xiong M, Han L, Sun Z, Zhang H, Liu H, Yu G, Shi P, Xu J, Wu M, Guo Z, Xiong Y, Duan C, Sun J, Liu Q, Zhang Y.
Yu S, et al. Among authors: zhang q, zhang h, zhang y.
JAMA Netw Open. 2021 Jul 1;4(7):e2115991. doi: 10.1001/jamanetworkopen.2021.15991.
JAMA Netw Open. 2021.
PMID: 34232303
Free PMC article.